Merck & Co. said its second-quarter earnings surged thanks to a one-time gain that masked a modest decline in revenue. The pharmaceutical company raised the low end of its per-share earnings estimate for the year.
WSJ.com: What's News US, Wall Street Journal
Tue, 07/29/2014 - 4:31am
Merck & Co. said its second-quarter earnings surged thanks to a one-time gain that masked a modest decline in revenue. The pharmaceutical company raised the low end of its per-share earnings estimate for the year.